
    
      This study will provide further insight whether anti-IL6 alone provide same efficacy and
      clinical outcome with reasonable side effects profile compared to anti-IL6 + corticosteroid
      and might serve as a corticosteroid sparing agents in COVID-19 patient with cytokine storms.
      Data elements will be retrieved from VIRUS registry which is a prospective,
      non-interventional, multi-center, multi-national observational cross sectional study
    
  